HDAC6 and neoplasm: The analysis of 33 tumours using multiple data sources from The Cancer Genome Atlas (TCGA) and the NCI-60 drug screening database revealed that most tumours exhibited lower levels of HDAC6 and HDAC10 compared to normal tissues [43].